{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:46:14Z","timestamp":1793090774778,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,23]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe coronavirus disease 2019 (COVID-19) is characterized by lung injury, cytokine storm, and increased neutrophil-to-lymphocyte ratio (NLR). Current therapies focus on reducing viral replication and inflammatory responses, but no specific treatment exists to prevent the development of severe COVID-19 in infected individuals. Angiotensin-converting enzyme-2 (ACE2) is the receptor for SARS-CoV-2, the virus causing COVID-19, but it is also critical for maintaining the correct functionality of lung epithelium and endothelium. Coronaviruses induce activation of a disintegrin and metalloprotease 17 (ADAM17) and shedding of ACE2 from the cell surface resulting in exacerbated inflammatory responses. Thus, we hypothesized that ADAM17 inhibition ameliorates COVID-19-related lung inflammation. We employed a preclinical mouse model using intratracheal instillation of a combination of polyinosinic:polycytidylic acid (poly(I:C)) and the receptor-binding domain of the SARS-CoV-2 spike protein (RBD-S) to mimic lung damage associated with COVID-19. Histologic analysis of inflamed mice confirmed the expected signs of lung injury including edema, fibrosis, vascular congestion, and leukocyte infiltration. Moreover, inflamed mice also showed an increased NLR as observed in critically ill COVID-19 patients. Administration of the ADAM17\/MMP inhibitors apratastat and TMI-1 significantly improved lung histology and prevented leukocyte infiltration. Reduced leukocyte recruitment could be explained by reduced production of proinflammatory cytokines and lower levels of the endothelial adhesion molecules ICAM-1 and VCAM-1. Additionally, the NLR was significantly reduced by ADAM17\/MMP inhibition. Thus, we propose inhibition of ADAM17\/MMP as a novel promising treatment strategy in SARS-CoV-2-infected individuals to prevent the progression toward severe COVID-19.<\/jats:p>","DOI":"10.1002\/jlb.3cova0421-195rr","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T18:04:24Z","timestamp":1637949864000},"page":"1147-1158","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["ADAM17\/MMP inhibition prevents neutrophilia and lung injury in a mouse model of COVID-19"],"prefix":"10.1093","volume":"111","author":[{"given":"Nathaniel L","family":"Lartey","sequence":"first","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Valle-Reyes","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda","family":"Vargas-Robles","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina E","family":"Jim\u00e9nez-Camacho","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idaira M","family":"Guerrero-Fonseca","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Castellanos-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Montoya-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Garc\u00eda-Cordero","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Cedillo-Barr\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Porfirio","family":"Nava","sequence":"additional","affiliation":[{"name":"Department of Physiology, Biophysics and Neurosciences, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica G","family":"Filisola-Villase\u00f1or","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Roa-Vel\u00e1zquez","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan I","family":"Zavala-Vargas","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1139-2292","authenticated-orcid":false,"given":"Edgar","family":"Morales-R\u00edos","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Citlaltepetl","family":"Salinas-Lara","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Neurolog\u00eda , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5939-8031","authenticated-orcid":false,"given":"Eduardo","family":"Vadillo","sequence":"additional","affiliation":[{"name":"Oncology Research Unit, Hospital de Oncolog\u00eda, Centro M\u00e9dico Nacional Siglo XXI , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0269-5884","authenticated-orcid":false,"given":"Michael","family":"Schnoor","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, CINVESTAV-IPN , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020","volume":"69","author":"Team CDC COVID-19 Response","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/SHK.0000000000001585","article-title":"Neutrophil-to-lymphocyte ratio and outcomes in Louisiana COVID-19 patients","volume":"54","author":"Tatum","year":"2020","journal-title":"Shock"},{"key":"2023032108504558000_","article-title":"A shift towards an immature myeloid profile in peripheral blood of critically Ill COVID-19 patients","author":"Vadillo","year":"2020","journal-title":"Arch Med Res"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3389\/fphar.2020.00870","article-title":"Neutrophilia and NETopathy as key pathologic drivers of progressive lung impairment in patients with COVID-19","volume":"11","author":"Narasaraju","year":"2020","journal-title":"Front Pharmacol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1172\/JCI143331","article-title":"Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome","volume":"130","author":"Matthay","year":"2020","journal-title":"J Clin Invest"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: sARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ Res"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41374-019-0289-7","article-title":"Ang-(1-7) treatment attenuates lipopolysaccharide-induced early pulmonary fibrosis","volume":"99","author":"Cao","year":"2019","journal-title":"Lab Invest"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.bbamcr.2017.07.001","article-title":"The shedding protease ADAM17: physiology and pathophysiology","volume":"1864","author":"Zunke","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000001740","article-title":"Immunopathological roles of neutrophils in virus infection and COVID-19","author":"Cui","year":"2021","journal-title":"Shock"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"8829674","DOI":"10.1155\/2020\/8829674","article-title":"COVID-19 and neutrophils: the relationship between hyperinflammation and neutrophil extracellular traps","volume":"2020","author":"Borges","year":"2020","journal-title":"Mediators Inflamm"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fcimb.2017.00138","article-title":"Ectodomain shedding by ADAM17: its role in neutrophil recruitment and the impairment of this process during sepsis","volume":"7","author":"Mishra","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ndt\/gfaa093","article-title":"ADAM17 inhibition may exert a protective effect on COVID-19","volume":"35","author":"Palau","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.367.6485.1412","article-title":"Race to find COVID-19 treatments accelerates","volume":"367","author":"Kupferschmidt","year":"2020","journal-title":"Science"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/21645515.2018.1520581","article-title":"Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice","volume":"15","author":"de la Cruz","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"621441","DOI":"10.3389\/fimmu.2020.621441","article-title":"Cytokine signature induced by SARS-CoV-2 spike protein in a mouse model","volume":"11","author":"Gu","year":"2020","journal-title":"Front Immunol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"F323","DOI":"10.1152\/ajprenal.00522.2012","article-title":"ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice","volume":"305","author":"Ford","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/jpet.103.059675","article-title":"Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecar boxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme\/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis","volume":"309","author":"Zhang","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.3389\/fmicb.2018.03174","article-title":"TLR3 regulated Poly(I:c)-induced neutrophil extracellular traps and acute lung injury partly through p38 MAP kinase","volume":"9","author":"Gan","year":"2018","journal-title":"Front Microbiol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2287","article-title":"Murine bronchoalveolar lavage","volume":"7","author":"Sun","year":"2017","journal-title":"Bio Protoc"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1746-6148-9-123","article-title":"Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology\u2013a systematic review","volume":"9","author":"Klopfleisch","year":"2013","journal-title":"BMC Vet Res"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2020.8907","article-title":"Postmortem examination of patients with COVID-19","volume":"323","author":"Schaller","year":"2020","journal-title":"JAMA"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s13054-020-03374-8","article-title":"Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis","volume":"24","author":"Li","year":"2020","journal-title":"Crit Care"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3389\/fphar.2020.01169","article-title":"Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention","volume":"11","author":"Hussman","year":"2020","journal-title":"Front Pharmacol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"576745","DOI":"10.3389\/fimmu.2020.576745","article-title":"ACE2\/ADAM17\/TMPRSS2 interplay may be the main risk factor for COVID-19","volume":"11","author":"Zipeto","year":"2020","journal-title":"Front Immunol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nri3908","article-title":"How leukocytes cross the vascular endothelium","volume":"15","author":"Vestweber","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"e1009392","DOI":"10.1371\/journal.ppat.1009392","article-title":"Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry","volume":"17","author":"Ren","year":"2021","journal-title":"PLoS Pathog"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","article-title":"A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures","volume":"586","author":"Dinnon","year":"2020","journal-title":"Nature"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J Virol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J Virol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1182\/blood.2019000685","article-title":"L-selectin shedding affects bacterial clearance in the lung: a new regulatory pathway for integrin outside-in signaling","volume":"134","author":"Cappenberg","year":"2019","journal-title":"Blood"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1189\/jlb.1109763","article-title":"In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis","volume":"87","author":"Long","year":"2010","journal-title":"J Leukoc Biol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2010-11-321406","article-title":"Adam17-dependent shedding limits early neutrophil influx but does not alter early monocyte recruitment to inflammatory sites","volume":"118","author":"Tang","year":"2011","journal-title":"Blood"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.it.2019.04.010","article-title":"Neutrophil recruitment: from model systems to tissue-specific patterns","volume":"40","author":"Margraf","year":"2019","journal-title":"Trends Immunol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41577-020-00470-2","article-title":"Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19","volume":"21","author":"Alon","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1386207053258488","article-title":"Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules","volume":"8","author":"Ludwig","year":"2005","journal-title":"Comb Chem High Throughput Screen"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ncprheum0797","article-title":"Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis","volume":"4","author":"Moss","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2023032108504558000_","first-page":"1014","article-title":"Drug evaluation: apratastat, a novel TACE\/MMP inhibitor for rheumatoid arthritis","volume":"7","author":"Thabet","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"2023032108504558000_","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0091270010372389","article-title":"Pharmacokinetic-pharmacodynamic modeling of apratastat: a population-based approach","volume":"51","author":"Shu","year":"2011","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.3COVA0421-195RR","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.3COVA0421-195RR","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/111\/6\/1147\/49467512\/jlb11050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/111\/6\/1147\/49467512\/jlb11050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T03:03:33Z","timestamp":1726196613000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/111\/6\/1147\/6885166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,11,26]]},"published-print":{"date-parts":[[2022,5,23]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.3cova0421-195rr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6]]},"published":{"date-parts":[[2021,11,26]]},"assertion":[{"value":"2021-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}